Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: What is the recommended assessment and management of women with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise and consumer preference? SUMMARY ANSWER: International evidence-based guidelines, including 166 recommendations and practice points, addressed prioritized questions to promote consistent, evidence-based care and improve the experience and health outcomes of women with PCOS. WHAT IS KNOWN ALREADY: Previous guidelines either lacked rigorous evidence-based processes, did not engage consumer and international multidisciplinary perspectives, or were outdated. Diagnosis of PCOS remains controversial, and assessment and management are inconsistent. The needs of women with PCOS are not being adequately met and evidence practice gaps persist. STUDY DESIGN, SIZE, DURATION: International evidence-based guideline development engaged professional societies and consumer organizations with multidisciplinary experts and women with PCOS directly involved at all stages. Appraisal of Guidelines for Research and Evaluation (AGREE) II-compliant processes were followed, with extensive evidence synthesis. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework was applied across evidence quality, feasibility, acceptability, cost, implementation and ultimately recommendation strength. PARTICIPANTS/MATERIALS, SETTING, METHODS: Governance included a six continent international advisory and a project board, five guideline development groups, and consumer and translation committees. Extensive health professional and consumer engagement informed guideline scope and priorities. Engaged international society-nominated panels included pediatrics, endocrinology, gynecology, primary care, reproductive endocrinology, obstetrics, psychiatry, psychology, dietetics, exercise physiology, public health and other experts, alongside consumers, project management, evidence synthesis and translation experts. In total, 37 societies and organizations covering 71 countries engaged in the process. Twenty face-to-face meetings over 15 months addressed 60 prioritized clinical questions involving 40 systematic and 20 narrative reviews. Evidence-based recommendations were developed and approved via consensus voting within the five guideline panels, modified based on international feedback and peer review, with final recommendations approved across all panels. MAIN RESULTS AND THE ROLE OF CHANCE: The evidence in the assessment and management of PCOS is generally of low to moderate quality. The guideline provides 31 evidence based recommendations, 59 clinical consensus recommendations and 76 clinical practice points all related to assessment and management of PCOS. Key changes in this guideline include: (i) considerable refinement of individual diagnostic criteria with a focus on improving accuracy of diagnosis; (ii) reducing unnecessary testing; (iii) increasing focus on education, lifestyle modification, emotional wellbeing and quality of life; and (iv) emphasizing evidence based medical therapy and cheaper and safer fertility management. LIMITATIONS, REASONS FOR CAUTION: Overall evidence is generally low to moderate quality, requiring significantly greater research in this neglected, yet common condition, especially around refining specific diagnostic features in PCOS. Regional health system variation is acknowledged and a process for guideline and translation resource adaptation is provided. WIDER IMPLICATIONS OF THE FINDINGS: The international guideline for the assessment and management of PCOS provides clinicians with clear advice on best practice based on the best available evidence, expert multidisciplinary input and consumer preferences. Research recommendations have been generated and a comprehensive multifaceted dissemination and translation program supports the guideline with an integrated evaluation program. STUDY FUNDING/COMPETING INTEREST(S): The guideline was primarily funded by the Australian National Health and Medical Research Council of Australia (NHMRC) supported by a partnership with ESHRE and the American Society for Reproductive Medicine. Guideline development group members did not receive payment. Travel expenses were covered by the sponsoring organizations. Disclosures of conflicts of interest were declared at the outset and updated throughout the guideline process, aligned with NHMRC guideline processes. Full details of conflicts declared across the guideline development groups are available at https://www.monash.edu/medicine/sphpm/mchri/pcos/guideline in the Register of disclosures of interest. Of named authors, Dr Costello has declared shares in Virtus Health and past sponsorship from Merck Serono for conference presentations. Prof. Laven declared grants from Ferring, Euroscreen and personal fees from Ferring, Euroscreen, Danone and Titus Healthcare. Prof. Norman has declared a minor shareholder interest in an IVF unit. The remaini
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such weight management strategies should encompass multidisciplinary lifestyle interventions, comprising of dietary, exercise and behavioural therapies [10].”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although moderate certainty evidence also suggests that metformin results in a substantially greater number of GI AEs than MI, we note that these adverse events are generally mild and self-limiting (5) and that a sensitivity analysis on studies judged to be at low risk of bias did not detect a difference between groups for GI AEs.”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Lifestyle interventions are first-line treatments, however attrition in women with PCOS is high.”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Metformin, a biguanide that decreases hepatic glucose production and increases body insulin sensitivity, is recommended in the 2018 international evidence-based PCOS guideline (5) for management of anthropometric and metabolic outcomes in PCOS.”
The cited source says what the claim attributes to it.
In the citing paper
“Extended-release preparations may also decrease the gastrointestinal side effects.2,66”
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
AGREE II: advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090449 · Cited by 3,790
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Self-citationAzziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Self-citationTeede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Self-citationBalen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw025 · Cited by 705
Self-citationThe polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Self-citationGoodman, N. F., Cobin, R. H., Futterweit, W., Glueck, J. S., Legro, R. S., & Carmina, E. (2015) · Endocrine Practice · doi:10.4158/ep15748.dsc · Cited by 623
Self-citationGibson-Helm, M., Teede, H., Dunaif, A., & Dokras, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2963 · Cited by 428
Self-citation
Cited by
Items 201–300 of 1,000
Ciężki, S., Kurpiewska, E., Bossowski, A. T., & Głowińska‐Olszewska, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.890833 · Cited by 60
Genazzani, A. R., Fidecicchi, T., Arduini, D., Giannini, A., & Simoncini, T. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2247093 · Cited by 141
Silva, I. S., Ferreira, C. N., Costa, L. B. X., Sóter, M. O., Carvalho, L. M. L., Albuquerque, J. D. C., Sales, M. F., Cândido, A. L., dos Reis, F. M., Veloso, A., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01672-8 · Cited by 55
Non-alcoholic fatty liver disease in polycystic ovary syndrome women
Won, Y. B., Seo, S. K., Yun, B. H., Cho, S., Choi, Y. S., & Lee, B. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-86697-y · Cited by 53
Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis
Piovezan, J. M., Premaor, M. O., & Comim, F. V. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz020 · Cited by 50
Kataoka, J., Larsson, I., Björkman, S., Eliasson, B., Schmidt, J., & Stener‐Victorin, E. (2019) · Clinical Endocrinology · doi:10.1111/cen.14098 · Cited by 52
Self-citationJensterle, M., Kravos, N. A., Ferjan, S., Goričar, K., Dolžan, V., & Janež, A. (2020) · Endocrine Connections · doi:10.1530/ec-19-0449 · Cited by 54
Jarrett, B. Y., Brink, H. V., Oldfield, A. L., & Lujan, M. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa515 · Cited by 54
Self-citationChen, X., Koivuaho, E., Piltonen, T., Gissler, M., & Lavebratt, C. (2021) · Human Reproduction · doi:10.1093/humrep/deab112 · Cited by 51
Self-citationKim, J., Hwang, K. R., Chae, S. J., Yoon, S. H., & Choi, Y. M. (2020) · Human Reproduction · doi:10.1093/humrep/deaa012 · Cited by 48
Ezeh, U., Chen, I. Y.-D., Chen, Y.-H., & Azziz, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa235 · Cited by 44
Self-citationRisk of foetal harm with letrozole use in fertility treatment: a systematic review and meta-analysis
Pundir, J., Achilli, C., Bhide, P., Sabatini, L., Legro, R. S., Rombauts, L. J. F., Teede, H. J., Coomarasamy, A., Zamora, J., & Thangaratinam, S. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa055 · Cited by 50
Self-citationAnagnostis, P. G., Paparodis, R. D., Bosdou, J. Κ., Bothou, C., Μacut, D., Goulis, D. G., & Livadas, S. (2021) · Endocrine · doi:10.1007/s12020-021-02801-2 · Cited by 52
Song, Y., Ye, W., Ye, H., Xie, T., Shen, W., & Zhou, L. (2019) · Physiological Reports · doi:10.14814/phy2.14219 · Cited by 52
Polyzos, N. P., Neves, A. R., Drakopoulos, P., Spits, C., Mercadal, B. A., García, S., M, P. Q., Le, L. H., Ho, T. M., Mertens, J., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab068 · Cited by 47
Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue
Wawrzkiewicz–Jałowiecka, A., Lalik, A., & Soveral, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105226 · Cited by 50
Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity
Hudnut‐Beumler, J., Kaar, J. L., Taylor, A., Kelsey, M. M., Nadeau, K. J., Zeitler, P., Snell‐Bergeon, J., Pyle, L., & Cree‐Green, M. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13206 · Cited by 46
Hager, M., Wenzl, R., Riesenhuber, S., Marschalek, J., Kuessel, L., Mayrhofer, D., Ristl, R., Kurz, C., & Ott, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081210 · Cited by 46
Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health
Brennan, K. M., Kroener, L. L., Chazenbalk, G. D., & Dumesic, D. A. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000661 · Cited by 48
Gadalla, M. A., Norman, R. J., Tay, C. T., Hiam, D., Melder, A., Pundir, J., Thangaratinam, S., Teede, H. J., Mol, B. W., & Moran, L. (2020) · Monash University Research Portal (Monash University) · doi:10.22074/ijfs.2020.5608 · Cited by 55
Self-citationLow anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment
Peuranpää, P., Hautamäki, H., Halttunen, M., Hydén‐Granskog, C., & Tiitinen, A. E. (2020) · Human Reproduction · doi:10.1093/humrep/deaa008 · Cited by 47
Estienne, A., Bongrani, A., Ramé, C., Kurowska, P., Błaszczyk, K., Rak, A., Ducluzeau, P., Froment, P., & Dupont, J. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111113 · Cited by 48
SMOTE-Based Automated PCOS Prediction Using Lightweight Deep Learning Models
Ahmad, R., Maghrabi, L. A., Khaja, I. A., Maghrabi, L. A., & Ahmad, M. (2024) · Diagnostics · doi:10.3390/diagnostics14192225 · Cited by 52
Vanky, E., Hanem, L. G. E., & Abbott, D. H. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.03.015 · Cited by 48
Self-citationTay, C. T., Teede, H. J., Loxton, D., Kulkarni, J., & Joham, A. E. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104678 · Cited by 41
Self-citationVagios, S., James, K. E., Sacha, C. R., Hsu, J. Y., Dimitriadis, I., Bormann, C. L., & Souter, I. C. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.07.023 · Cited by 49
Higher blood pressure in normal weight women with PCOS compared to controls
Mellembakken, J. R., Mahmoudan, A., Mørkrid, L., Poromaa, I. S., Morin-Papunen, L. C., Tapanainen, J. S., Piltonen, T., Hirschberg, A. L., Stener‐Victorin, E., Vanky, E., et al. (2021) · Endocrine Connections · doi:10.1530/ec-20-0527 · Cited by 46
Self-citationRyu, K.-J., Kim, M. S., Kim, H. K., Kim, Y. J., Yi, K. W., Shin, J., Hur, J. Y., Kim, T., & Park, H. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.12.018 · Cited by 49
Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
Genazzani, A. D., & Genazzani, A. R. (2023) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2023.19.1.71 · Cited by 48
Anxiety, depression, and body image among infertile women with and without polycystic ovary syndrome
Jannink, T. I., Bordewijk, E. M., Aalberts, J. L., Hendriks, J., Lehmann, V., Hoek, A., Goddijn, M., van Wely, M., ANDES study group, de Bruin, J. P., et al. (2024) · Human Reproduction · doi:10.1093/humrep/deae016 · Cited by 46
Wu, L., Wang, Y.-X., Zhan, Y., Liu, A.-H., Wang, Y., Shen, H., Wang, Y.-F., Wang, L., Tao, Z., & Wang, Y. (2021) · Peptides · doi:10.1016/j.peptides.2021.170624 · Cited by 44
Ge, J. J., Wang, D., Song, W., Shen, S., & Ge, W. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01666-6 · Cited by 47
High androgen concentrations in follicular fluid of polycystic ovary syndrome women
Bongrani, A., Plotton, I., Mellouk, N., Ramé, C., Guérif, F., Froment, P., & Dupont, J. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00959-6 · Cited by 46
Fertility concerns and related information needs and preferences of women with PCOS
Holton, S., Hammarberg, K., & Johnson, L. (2018) · Human Reproduction Open · doi:10.1093/hropen/hoy019 · Cited by 43
Self-citationYang, P.-K., Chou, C.-H., Chang, C., Chen, S., Ho, H., & Chen, M. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00629-5 · Cited by 45
Robin, C., Uk, A., Decanter, C., Béhal, H., Collinet, P., Rubod, C., Barbotin, A., & Robin, G. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00798-x · Cited by 46
Fadlalmola, H. A., Elhusein, A. M., Al‐Sayaghi, K. M., Albadrani, M. S., Swamy, D. S. V., Mamanao, D. M., El-Amin, E. I., Ibrahim, S. E., & Abbas, S. M. (2023) · Pan African Medical Journal · doi:10.11604/pamj.2023.44.134.32404 · Cited by 47
Rambaran, N., & Islam, M. S. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i7.108789 · Cited by 48
He, Y., Tian, J., Blizzard, L., Oddy, W. H., Dwyer, T., Bazzano, L. A., Hickey, M., Harville, E. W., & Venn, A. J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa069 · Cited by 39
Akbari Sene, A., Tabatabaie, A., Nikniaz, H., Alizadeh, A., Sheibani, K., Mortezapour Alisaraie, M., Tabatabaie, M., Ashrafi, M., & Amjadi, F. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05111-1 · Cited by 42
Update on Animal Models of Polycystic Ovary Syndrome
Stener‐Victorin, E. (2022) · Endocrinology · doi:10.1210/endocr/bqac164 · Cited by 46
Self-citationAyesh, H., Nasser, S. A., Ferdinand, K. C., & Leon, B. G. C. (2025) · Circulation Research · doi:10.1161/circresaha.124.325535 · Cited by 45
Vale-Fernandes, E., Pignatelli, D., & Monteiro, M. P. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf062 · Cited by 47
Wu, C.-H., Chiu, L., Chang, Y., Lee, C., Lee, M., Lee, T., & Wei, J. C. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.574651 · Cited by 46
Ran, Y., Yi, Q., Li, C., Qiao, H., Yang, Q., & Ye, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s299558 · Cited by 52
Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients—The Debate Is Still Open
Kruszewska, J., Laudy-Wiaderny, H., & Kunicki, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042099 · Cited by 49
Fertility Treatment Options for Women With Polycystic Ovary Syndrome
Sawant, S., & Bhide, P. (2019) · Clinical Medicine Insights Reproductive Health · doi:10.1177/1179558119890867 · Cited by 49
Strategies to reduce multiple pregnancies during medically assisted reproduction
Bergh, C., Kamath, M. S., Wang, R., & Lensen, S. F. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.07.022 · Cited by 47
Polycystic ovary syndrome and obesity: clinical aspects and nutritional management
FRIAS-TORAL, E., GARCIA-VELASQUEZ, E., de los ANGELES CARIGNANO, M., RODRIGUEZ-VEINTIMILLA, D., ALVARADO-AGUILERA, I., & BAUTISTA-LITARDO, N. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03349-6 · Cited by 40
Targeted gene expression profiling for accurate endometrial receptivity testing
Meltsov, A., Saare, M., Teder, H., Paluoja, P., Arffman, R. K., Piltonen, T., Laudański, P., Wielgoś, M., Gianaroli, L., Koel, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40991-z · Cited by 46
Self-citationIsmayilova, M., & Yaya, S. (2022) · BMC Women's Health · doi:10.1186/s12905-022-01734-w · Cited by 40
Kazemi, M., McBreairty, L. E., Zello, G. A., Pierson, R. A., Gordon, J. J., Serrao, S. B., Chilibeck, P. D., & Chizen, D. R. (2020) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2019.1666820 · Cited by 40
Spritzer, P. M., Marchesan, L. B., dos Santos, B. R., Cureau, F. V., Oppermann, K., dos Reis, R. M., Ferriani, R. A., Weiss, R. V., Meirelles, R. M. R., Cândido, A. L., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029191 · Cited by 43
Self-citationPolycystic ovary syndrome in adult women
Ortiz-Flores, A. E., Luque-Ramírez, M., & Escobar-Morreale, H. F. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2019.02.019 · Cited by 37
Bülow, N. S., Skouby, S. O., Warzecha, A. K., Udengaard, H., Andersen, C. Y., Holt, M. D., Grøndahl, M. L., Andersen, A. N., Sopa, N., Englund, A. L. M., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab249 · Cited by 41
Insulin resistance in polycystic ovary syndrome: concept versus cutoff
Greenwood, E. A., & Huddleston, H. G. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.08.100 · Cited by 46
Decidualized endometrial stromal cells present with altered androgen response in PCOS
Khatun, M., Meltsov, A., Lavõgina, D., Loid, M., Kask, K., Arffman, R. K., Rossi, H., Lättekivi, F., Jääger, K., Krjutškov, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95705-0 · Cited by 41
Self-citationWang, G., Liu, X., Zhu, S., & Lei, J. (2023) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2023.2218987 · Cited by 45
Williams, N., Souza, M. D. D., Misra, M., Nattiv, A., Joy, E., Barrack, M., Ricker, E. A., Gorrell, S., Koltun, K., O'Donnell, E., et al. (2025) · Sports Medicine · doi:10.1007/s40279-025-02332-0 · Cited by 31
Adherence to treatment for polycystic ovarian syndrome: A systematic review
Parker, M., Warren, A., Nair, S., & Barnard, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228586 · Cited by 45
Tay, C. T., Moran, L. J., Harrison, C. L., Brown, W. J., & Joham, A. E. (2020) · Clinical Endocrinology · doi:10.1111/cen.14205 · Cited by 39
Self-citationGreenwood, E. A., Pasch, L. A., Cedars, M. I., & Huddleston, H. G. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.01.016 · Cited by 41
Prevalence of Polycystic Ovarian Syndrome Among Adolescents and Young Women in India
Mehreen, T. S., Ranjani, H., Kamalesh, R., Ram, U., Anjana, R. M., & Mohan, V. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_105_20 · Cited by 55
Transtheoretical model-based mobile health application for PCOS
Wang, L., Liu, Y., Tan, H., & Huang, S. (2022) · Reproductive Health · doi:10.1186/s12978-022-01422-w · Cited by 38
Mizgier, M., Jarząbek‐Bielecka, G., Formanowicz, D., Jodłowska-Siewert, E., Mruczyk, K., Cisek-Woźniak, A., Kędzia, W., & Opydo-Szymaczek, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163469 · Cited by 39
Silva, M. S. B., Decoster, L., Delpouve, G., Lhomme, T., Ternier, G., Prévot, V., & Giacobini, P. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104850 · Cited by 41
Unravelling Polycystic Ovary Syndrome and Its Comorbidities
Kim, K.-W. (2021) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes21043 · Cited by 44
Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2019) · Endocrine Connections · doi:10.1530/ec-19-0377 · Cited by 40
Self-citationClinicians’ perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study
Copp, T., Muscat, D. M., Hersch, J., McCaffery, K. J., Doust, J., Mol, B. W., Dokras, A., & Jansen, J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa005 · Cited by 37
Self-citationAsdaq, S. M. B., Jomah, S., Hasan, R., Al-Baroudi, D., Alharbi, M., Alsubaie, S., Buhamad, M. H., Alyahya, B., & Al‐Yamani, M. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.08.039 · Cited by 42
Mizgier, M., Jarząbek‐Bielecka, G., Opydo-Szymaczek, J., Wendland, N., Więckowska, B., & Kędzia, W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9093041 · Cited by 41
Kazemi, M., Pierson, R. A., McBreairty, L. E., Chilibeck, P. D., Zello, G. A., & Chizen, D. R. (2020) · Clinical Endocrinology · doi:10.1111/cen.14179 · Cited by 36
Moore, A. M. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70028 · Cited by 39
Krentowska, A., Łebkowska, A., Jacewicz‐Święcka, M., Hryniewicka, J., Leśniewska, M., Adamska, A., & Kowalska, I. (2021) · Endocrine · doi:10.1007/s12020-020-02596-8 · Cited by 40
Clinical Utility of Anti-Mullerian Hormone in Pediatrics
Shankar, R. K., Dowlut‐McElroy, T., Dauber, A. N., & Gomez‐Lobo, V. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab687 · Cited by 42
Cognitive behavioural therapy for depression in women with PCOS: systematic review and meta-analysis
Jiskoot, G., van der Kooi, A.-L., Busschbach, J. J. V., Laven, J. S. E., & Beerthuizen, A. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.05.001 · Cited by 40
Self-citationA new evidence‐based guideline for assessment and management of polycystic ovary syndrome
Norman, R. J., & Teede, H. J. (2018) · Medical Journal of Australia · doi:10.5694/mja18.00635 · Cited by 35
Self-citationFeyzioglu, B. S., Güven, C. M., & Avul, Z. (2023) · Nutrients · doi:10.3390/nu15102260 · Cited by 33
Liu, C., Dou, Y., Zhang, M., Han, S., Hu, S., Li, Y., Yu, Z., Liu, Y., Liang, X., Chen, Z., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04952-y · Cited by 39
Reka, S., Praba, T. S., Prasanna, M., Reddy, V. N. N., & Amirtharajan, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-01744-2 · Cited by 35
Babapour, M., Mohammadi, H., Kazemi, M., Hadi, A., Rezazadegan, M., & Askari, G. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02275-9 · Cited by 40
Long non-coding RNAs: novel players in the pathogenesis of polycystic ovary syndrome
Tu, M., Wu, Y., Mu, L., & Zhang, D. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5044 · Cited by 35
Liu, Y., Li, J., Yan, Z., Liu, D., Ma, J., & Tong, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.657889 · Cited by 39
Wang, Z., Zhao, J., Ma, X., Sun, Y. W., Hao, G., Yang, A., Ren, W., Jin, L., Lu, Q., Wu, G., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab340 · Cited by 37
An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome
Zhao, J., Chen, Q., & Xue, X. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00641-z · Cited by 37
The Content of Minerals in the PCOS Group and the Correlation with the Parameters of Metabolism
Pokorska‐Niewiada, K., Brodowska, A., & Szczuko, M. (2021) · Nutrients · doi:10.3390/nu13072214 · Cited by 38
Maleki, V., Faghfouri, A. H., Tabrizi, F. P. F., Moludi, J., Saleh‐Ghadimi, S., Vayghan, H. J., & Qaisar, S. A. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00870-5 · Cited by 38
Kim, C., Catov, J. M., Schreiner, P. J., Appiah, D., Wellons, M., Siscovick, D. S., Calderon‐Margalit, R., Huddleston, H. G., Ebong, I., & Lewis, C. E. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028132 · Cited by 40
The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
Sivanandy, M. S., & Ha, S. K. (2023) · Diagnostics · doi:10.3390/diagnostics13050907 · Cited by 46
Costello, M., Garad, R. M., Hart, R. J., Homer, H. A., Johnson, L., Jordan, C., Mocanu, E. V., Qiao, J., Rombauts, L. J. F., Teede, H. J., et al. (2019) · Medical Sciences · doi:10.3390/medsci7090095 · Cited by 43
Self-citationIs polycystic ovary syndrome a 20th Century phenomenon?
Rodgers, R. J., Suturina, L., Lizneva, D., Davies, M. J., Hummitzsch, K., Irving-Rodgers, H. F., & Robertson, S. A. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.01.019 · Cited by 34
Self-citationHuang, X., Geng, H., Liang, C., Xiong, X., Du, X., Zhuan, Q., Liu, Z., Lin, M., Zhou, D., Zhang, L., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.021 · Cited by 34
Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome
Banaszewska, B., Pawelczyk, L. A., & Spaczyński, R. (2019) · Reproductive Biology · doi:10.1016/j.repbio.2019.09.006 · Cited by 42
Díaz, M., Bassols, J., López‐Bermejo, A., de Zegher, F., & Ibáñez, L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz204 · Cited by 34
Torres-Zegarra, C., Sundararajan, D., Benson, J., SEAGLE, H. M., Witten, M., Walders‐Abramson, N., Simon, S. L., Huguelet, P. S., Nokoff, N., & Cree‐Green, M. (2021) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2021.02.002 · Cited by 35
Weight management strategies for patients with PCOS: current perspectives
Ozgen Saydam, B., & Yildiz, B. O. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1896966 · Cited by 33
Light, R. S., Chilcot, J., & McBride, E. (2021) · Women's Health Issues · doi:10.1016/j.whi.2020.11.003 · Cited by 33
The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
Anala, A. D., Saifudeen, I. S. H., Ibrahim, M., Nanda, M., Naaz, N., & Atkin, S. L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144575 · Cited by 39
BMI and Polycystic Ovary Syndrome: Demographic Trends in Weight and Health
Mohapatra, I., & Samantaray, S. R. (2024) · Cureus · doi:10.7759/cureus.55439 · Cited by 37
Stefanaki, K., Karagiannakis, D. S., Peppa, Μ., Vryonidou, A., Kalantaridou, S., Goulis, D. G., Ψαλτοπούλου, Θ., & Paschou, S. Α. (2024) · Nutrients · doi:10.3390/nu16071049 · Cited by 35
Metadata
- Authors
- Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., Azziz, R., Balen, A., Baye, E., Boyle, J., Brennan, L., Broekmans, F., Dabadghao, P., Devoto, L., Dewailly, D., Downes, L., Fauser, B., Franks, S., Garad, R. M., Gibson-Helm, M., Harrison, C., Hart, R., Hawkes, R., Hirschberg, A., Hoeger, K., Hohmann, F., Hutchison, S., Joham, A., Johnson, L., Jordan, C., Kulkarni, J., Legro, R. S., Li, R., Lujan, M., Malhotra, J., Mansfield, D., Marsh, K., McAllister, V., Mocanu, E., Mol, B. W., Ng, E., Oberfield, S., Ottey, S., Peña, A., Qiao, J., Redman, L., Rodgers, R., Rombauts, L., Romualdi, D., Shah, D., Speight, J., Spritzer, P. M., Stener-Victorin, E., Stepto, N., Tapanainen, J. S., Tassone, E. C., Thangaratinam, S., Thondan, M., Tzeng, C.-R., van der Spuy, Z., Vanky, E., Vogiatzi, M., Wan, A., Wijeyaratne, C., Witchel, S., Woolcock, J., & Yildiz, B. O.
- Affiliations
- Monash Health (AU)
- UNSW Sydney (AU)
- University of Pennsylvania (US)
- Erasmus MC (NL)
- Oulu University Hospital (FI)
- National Health and Medical Research Council (AU)
- Odense University Hospital (DK)
- State University of New York (US)
- Leeds Teaching Hospitals NHS Trust (GB)
- Monash Centre for Health Research and Implementation, Australia
- Australian Catholic University (AU)
- University Medical Center Utrecht (NL)
- Sanjay Gandhi Post Graduate Institute of Medical Sciences (IN)
- Université de Lille (FR)
- Imperial College London (GB)
- Monash University (AU)
- Monash University, Australia
- The University of Western Australia (AU)
- Karolinska Institutet (SE)
- University of Rochester (US)
- Victorian Assisted Reproductive Treatment Authority, Australia
- Monash Alfred Psychiatry Research centre (AU)
- Pennsylvania State University (US)
- Cornell University (US)
- Northside Nutrition & Dietetics, Australia
- Royal College of Surgeons in Ireland (IE)
- Columbia University Irving Medical Center (US)
- The University of Adelaide (AU)
- Peking University Third Hospital (CN)
- Pennington Biomedical Research Center (US)
- Agostino Gemelli University Polyclinic (IT)
- Deakin University (AU)
- Universidade Federal do Rio Grande do Sul (BR)
- Karolinska Institutet, Sweden
- University of Helsinki (FI)
- Queen Mary University of London (GB)
- Taipei Medical University Hospital (TW)
- University of Cape Town (ZA)
- University of Cape Town, South Africa
- Children's Hospital of Philadelphia (US)
- University of Colombo (LK)
- University of Pittsburgh (US)
- Women's and Children's Hospital (AU)
- Hacettepe University School of Medicine, Ankara, Turkey
- Corresponding author
- Teede, Helena J
- ORCID
- Teede, Helena J
- Misso, Marie L
- Costello, Michael F
- Dokras, Anuja
- Laven, Joop
- Moran, Lisa
- Piltonen, Terhi
- Norman, Robert J
- Andersen, Marianne
- Azziz, Ricardo
- Balen, Adam
- Baye, Estifanos
- Boyle, Jacqueline
- Brennan, Leah
- Broekmans, Frank
- Dabadghao, Preeti
- Dewailly, Didier
- Fauser, Bart
- Franks, Stephen
- Garad, Rhonda M
- Harrison, Cheryce
- Hart, Roger
- Hirschberg, Angelica
- Hoeger, Kathleen
- Joham, Anju
- Johnson, Louise
- Jordan, Cailin
- Kulkarni, Jayashri
- Legro, Richard S
- Li, Rong
- Lujan, Marla
- Malhotra, Jaideep
- Mansfield, Darren
- Marsh, Kate
- Mocanu, Edgar
- Mol, Ben W
- Ng, Ernest
- Oberfield, Sharon
- Ottey, Sasha
- Peña, Alexia
- Qiao, Jie
- Redman, Leanne
- Rodgers, Raymond
- Rombauts, Luk
- Romualdi, Daniela
- Shah, Duru
- Speight, Jane
- Spritzer, Poli Mara
- Stepto, Nigel
- Tapanainen, Juha S
- Tassone, Eliza C
- Thangaratinam, Shakila
- Tzeng, Chii-Ruey
- Vanky, Eszter
- Vogiatzi, Maria
- Wijeyaratne, Chandrika
- Witchel, Selma
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-07-19
- Volume
- 33
- Issue
- 9
- Pages
- 1602-1618
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- PMC
- PMC6112576
- OpenAlex
- W4212784858
- Cited by
- 1,593
- References
- 14
- Citations by year
- 2026: 163 · 2025: 215 · 2024: 208 · 2023: 249 · 2022: 241 · 2021: 216 · 2020: 170 · 2019: 114 · 2018: 15
- FWCI
- 138.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Human Reproduction (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by-nc-nd)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by-nc-nd)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- Australian National Health and Medical Research Council (APP1078444)
- European Society of Human Reproduction and Embryology
- American society for Reproductive Medicine
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, PCOS diagnosis, PCOS management, diagnostic criteria, lifestyle modification, insulin resistance, hyperandrogenism, ovulation induction, contraception, emotional well-being, patient education, customer engagement, guideline recommendations, AGREE II, GRADE, multidisciplinary consensus, quality of life
- MeSH terms
- Female, Humans, Infertility, Female, Polycystic Ovary Syndrome, Pregnancy, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
